Kinsler, VA;
O'Hare, P;
Jacques, T;
Hargrave, D;
Slater, O;
(2017)
MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children.
British Journal of Cancer
10.1038/bjc.2017.49.
(In press).